NCT05881213

Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults

A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 23 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-378

Detailed description

A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety after Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults

Conditions

• Type II Diabetes

Interventions

Type	Name	Description
DRUG	CKD-378 (low-dose)	Quaque day (QD), PO

Timeline

• Start date: 2023-06-01
• Primary completion: 2023-06-28
• Completion: 2023-07-10
• First posted: 2023-05-31
• Last updated: 2023-12-19

Locations

1 site across 1 country: South Korea